MELISSA LOCKLEAR: Open Payments
NPI 1023355195 · ROWLAND, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$508 in 21 payments from 12 companies in 2025. Trend: 2023 $232 · 2024 $214 · 2025 $508
Food & beverage: $508
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $146 |
| Indivior Inc. | 3 | $85 |
| ABBVIE INC. | 4 | $74 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38 |
| Otsuka America Pharmaceutical, Inc. | 1 | $33 |
| Abbott Laboratories | 1 | $24 |
| ANI Pharmaceuticals, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Dexcom, Inc. | 1 | $17 |
Products named: Wegovy, SUBLOCADE, LINZESS, JARDIANCE, ABILIFY ASIMTUFII, FREESTYLE LIBRE 3, PURIFIED CORTROPHIN GEL, MOUNJARO.
Industry payments across NC — which companies pay providers there.
